黏液性卵巢癌的檢視

Mucinous ovarian carcinoma

黏性性卵巢癌（MOC）是一種少見的上皮性卵巢癌（EOC），約佔EOC的1/3。由於MOC特別的行為、分子醫學、對化學治療的反應，都與最常見的高度惡性漿液性卵巢癌不同。MOC常在早期時便被發現，預後良好，但對晚期和復發性病灶，化學治療常有抗藥性，因此需尋找新的治療方法，來改善復發病例欠佳的預後。

Mucinous ovarian carcinoma (MOC) is a rare histotype of epithelial ovarian cancer (EOC), comprising 3% of EOC cases. MOC represents a distinct entity from other histotypes of EOC due to its peculiar behavior, molecular profile, response to chemotherapy, and prognosis compared to the more common highgrade serous carcinoma. MOC typically presents at eraly stage but demonstrates intrinstic chemoresistance treatment of advanced-stage and relapsed disease is therefore challenging. Patients diagnosed with MOC are likely to experience excellent long-term survival. However, advanced stages at diagnosis are associated with poorer survival. New treatment options are urgently needed to improve survival following relapse, which is associated with extremely poor prognosis.